Bicycle Therapeutics Q3 Revenue Climbs 190.4% to $34.06 Million
Photo: TokenPost
Bicycle Therapeutics plc (NASDAQ: BCYC) posted third-quarter revenue of $34.06 million, up 190.4% year over year, while its GAAP loss per share was narrower than analysts expected. Revenue exceeded estimates by $21.86 million. GAAP earnings per share were a loss of $0.15, beating estimates by $0.33. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
